AXP
American Express Company
AXP has a slight edge over BAC overall, supported by stronger valuation.
BAC
Bank of America Corporation
BAC offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AXP Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
AXP's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like AXP.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
AXP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $276 | -13% |
| Forward | 16x | $318 | — |
| Current | 18x | $318 | — |
| Fair | 19x | $338 | +6.4% |
| Expensive | 23x | $407 | +28% |
Historical ranges are pointers, not guarantees.
AXP's PE is in its fair range at 18x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over AXP in the historical PE scenario, which offers more potential upside but is not a forecast.
AXP Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for AXP, with profitability improving.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
AXP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $19.38 | +9.2% |
| Q3 2026 | $17.75 | +19% |
| Q2 2026 | $16.47 | +16% |
| Q1 2026 | $16.02 | +12% |
| Q4 2025 | $15.38 | +9.8% |
| Q3 2025 | $14.90 | +9.6% |
| Q2 2025 | $14.25 | +6.3% |
| Q1 2025 | $14.32 | +18% |
| Q4 2024 | $14.01 | +25% |
AXP's earnings per share have climbed steadily: $17.75 over the past year, up 19% from the year before, and higher year over year for 14 quarters in a row.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over AXP on earnings, with stronger typical year-over-year growth.
AXP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.1B | +8.9% |
| Q2 2026 | $19.6B | +10% |
| Q1 2026 | $18.9B | +11% |
| Q4 2025 | $19B | +10% |
| Q3 2025 | $18.4B | +11% |
| Q2 2025 | $17.9B | +9.3% |
| Q1 2025 | $17B | +7.4% |
| Q4 2024 | $17.2B | +8.7% |
AXP's revenue has grown year over year for 22 quarters in a row: $20.1B last quarter, up 8.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +1.8 points |
| Q2 2026 | 21% | +0.9 points |
| Q1 2026 | 20% | +0.4 points |
| Q4 2025 | 16% | +0.2 points |
| Q3 2025 | 21% | +1.5 points |
| Q2 2025 | 20% | -3.3 points |
| Q1 2025 | 20% | -0.3 points |
| Q4 2024 | 16% | +0.1 points |
AXP's operating margin was 23% last quarter, up 1.8 points from the same quarter a year ago.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over AXP on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over AXP on profitability, with a higher operating margin.
AXP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.4B | -20% |
| Q2 2026 | $4.5B | +19% |
| Q1 2026 | $2.7B | -39% |
| Q4 2025 | $2.3B | -56% |
| Q3 2025 | $5.6B | +$7.8B |
| Q2 2025 | $3.7B | -5.6% |
| Q1 2025 | $4.3B | -16% |
| Q4 2024 | $5.3B | -17% |
AXP's free cash flow was $13.9B over the past year, down 27% from the year before. Free cash flow isn't a meaningful measure for financial services companies like AXP.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over AXP on cash flow, with more consistent year-over-year improvement.
AXP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -5M shares |
| 1 year | -2.7% | -19M shares |
| 3 years | -8% | -59M shares |
| 5 years | -14% | -113M shares |
| Available history | -19% | -156M shares |
AXP has 674M diluted shares, down 2.7% from a year ago, with $6.7B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.6B |
| Q2 2026 | $2.3B |
| Q1 2026 | $1.9B |
| Q4 2025 | $899M |
| Q3 2025 | $2.4B |
| Q2 2025 | $1.4B |
| Q1 2025 | $1.2B |
| Q4 2024 | $1B |
AXP spent $6.7B buying back its own shares over the past year, up 13% from the year before.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over AXP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
AXP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.2x | Elevated |
| Q2 2026 | 3.3x | Elevated |
| Q1 2026 | 3.6x | Elevated |
| Q4 2025 | 3.5x | Elevated |
| Q3 2025 | 3.7x | Elevated |
| Q2 2025 | 3.9x | Elevated |
| Q1 2025 | 3.4x | Elevated |
| Q4 2024 | 3.3x | Elevated |
AXP has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
AXP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 41.5 | Neutral |
AXP's weekly RSI is 47 (neutral) and its Stochastic is 41 (neutral).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
AXP PE vs Financial Services Sector
| Metric | AXP | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 13x | 38% above |
| PE % | 36 | 63 | 27 pts below |
AXP is trading at 18x earnings, a 38% premium to the Financial Services sector's median of 13x.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over AXP on valuation relative to its sector.
AXP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $313.1 | 1.6% above |
| 20 week MA | $327.0 | 2.7% below |
| 50 week MA | $331.4 | 4% below |
| 100 week MA | $319.7 | 0.5% below |
| 200 week MA | $261.5 | 22% above |
AXP has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
AXP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $125.2 | $117.4 | -6.3% |
| 2021 | $117.4 | $164.2 | +40% |
| 2022 | $164.2 | $147.0 | -10% |
| 2023 | $147.0 | $187.3 | +27% |
| 2024 | $187.3 | $301.1 | +61% |
| 2025 | $301.1 | $381.1 | +27% |
| 2026 YTD | $381.1 | $318.1 | -17% |
AXP has finished higher in four of the last six years. It's down 17% so far in 2026.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over AXP on returns for 2026, with the stronger performance.